Olin Corp (OLN):企業の財務・戦略的SWOT分析

◆英語タイトル:Olin Corp (OLN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C8338
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Olin Corp (OLN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Olin Corp (Olin) manufactures and distributes chemical products. Its product offering includes chlorine, caustic soda, methyl chloride, ethylene dichloride and vinyl chloride monomer, chloroform, methylene chloride, carbon tetrachloride, perchloroethylene, trichloroethylene and vinylidene chloride, hydrogen, hydrochloric acid, bleach products and potassium hydroxide. Olin produces epoxy materials including allyl chloride, liquid epoxy resins, epichlorohydrin, solid epoxy resins and additives. The company’s chemicals are widely used chemicals, which are further upgraded into a wide variety of downstream chemical products. It also produces and markets reloading components, sporting ammunition, small caliber military ammunition and components, and industrial cartridges. The company has operations in the US, Canada, South Korea, Germany, Italy, Australia, the Netherlands and Brazil. Olin Corp is headquartered in Clayton, Missouri, the US.

Olin Corp Key Recent Developments

Sep 20,2018: Scott M. Sutton appointed to Olin’s Board of Directors
Jul 31,2018: Olin announces second quarter 2018 earnings
May 01,2018: Olin Announces First Quarter 2018 Earnings
May 01,2018: Olin Announces First Quarter 2018 Earnings
Apr 25,2018: Olin Announces New Lead Director

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Olin Corp – Key Facts 6
Olin Corp – Key Employees 7
Olin Corp – Key Employee Biographies 8
Olin Corp – Major Products and Services 9
Olin Corp – History 10
Olin Corp – Company Statement 11
Olin Corp – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Company Overview 13
Olin Corp – Business Description 14
Business Segment: Chlor Alkali Products and Vinyls 14
Overview 14
Performance 14
Business Segment: Epoxy 14
Overview 14
Performance 14
Business Segment: Winchester 15
Overview 15
Performance 15
Geographical Segment: Foreign 15
Performance 15
Geographical Segment: The US 15
Performance 15
Olin Corp – Corporate Strategy 16
Olin Corp – SWOT Analysis 17
SWOT Analysis – Overview 17
Olin Corp – Strengths 17
Olin Corp – Weaknesses 18
Olin Corp – Opportunities 19
Olin Corp – Threats 20
Olin Corp – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios – Interim Ratios 27
Financial Ratios – Ratio Charts 28
Section 4 – Company’s Petrochemicals Financial Deals and Alliances 29
Olin Corp, Petrochemicals, Deals By Year, 2012 to YTD 2018 29
Olin Corp, Petrochemicals, Deals By Type, 2012 to YTD 2018 30
Olin Corp, Recent Deals Summary 31
Section 5 – Company’s Recent Developments 32
Sep 20, 2018: Scott M. Sutton appointed to Olin’s Board of Directors 32
Jul 31, 2018: Olin announces second quarter 2018 earnings 33
May 01, 2018: Olin Announces First Quarter 2018 Earnings 35
May 01, 2018: Olin Announces First Quarter 2018 Earnings 37
Apr 25, 2018: Olin Announces New Lead Director 39
Feb 06, 2018: Olin Announces Fourth Quarter 2017 Earnings 40
Feb 06, 2018: Olin Announces Fourth Quarter 2017 Earnings 43
Aug 31, 2017: Olin Declares Force Majeure For Product Shipments From Freeport, Texas 46
Jul 31, 2017: Olin Announces Second Quarter 2017 Earnings And Reiterates Full Year 2017 Guidance 47
Jun 19, 2017: Olin Updates Second Quarter 2017 Outlook 49
Section 6 – Appendix 50
Methodology 50
Ratio Definitions 50
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
Olin Corp, Key Facts 6
Olin Corp, Key Employees 7
Olin Corp, Key Employee Biographies 8
Olin Corp, Major Products and Services 9
Olin Corp, History 10
Olin Corp, Subsidiaries 12
Olin Corp, Key Competitors 21
Olin Corp, Ratios based on current share price 22
Olin Corp, Annual Ratios 23
Olin Corp, Annual Ratios (Cont...1) 24
Olin Corp, Annual Ratios (Cont...2) 25
Olin Corp, Interim Ratios 27
Olin Corp, Petrochemicals, Deals By Year, 2012 to YTD 2018 29
Olin Corp, Petrochemicals, Deals By Type, 2012 to YTD 2018 30
Olin Corp, Recent Deals Summary 31
Currency Codes 50
Capital Market Ratios 50
Equity Ratios 51
Profitability Ratios 51
Cost Ratios 52
Liquidity Ratios 52
Leverage Ratios 53
Efficiency Ratios 53

List of Figures
Olin Corp, Performance Chart (2013 - 2017) 26
Olin Corp, Ratio Charts 28
Olin Corp, Petrochemicals, Deals By Year, 2012 to YTD 2018 29
Olin Corp, Petrochemicals, Deals by Type, 2012 to YTD 2018 30

★海外企業調査レポート[Olin Corp (OLN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hokuriku Electric Power Co (9505):企業の財務・戦略的SWOT分析
    Hokuriku Electric Power Co (9505) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Eby-Brown Company LLC:企業の戦略・SWOT・財務情報
    Eby-Brown Company LLC - Strategy, SWOT and Corporate Finance Report Summary Eby-Brown Company LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Oramed Pharmaceuticals Inc (ORMP)-製薬・医療分野:企業M&A・提携分析
    Summary Oramed Pharmaceuticals Inc (Oramed) engages in the research and development of novel pharmaceutical solutions, comprising an oral insulin capsule for the treatment of individuals with diabetes, and orally ingestible capsules or pills for delivery of other polypeptides. It developed a unique …
  • Clovis Oncology Inc (CLVS):医療機器:M&Aディール及び事業提携情報
    Summary Clovis Oncology Inc (Clovis) is a biopharmaceutical company that acquires, develops and commercializes new anti-cancer agents. The company's development programs are targeted at specific cancer indications, combining personalized medicine with companion diagnostics. It develops and commercia …
  • Hasbro, Inc. (HAS):企業の財務・戦略的SWOT分析
    Hasbro, Inc. (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • SeQuent Scientific Ltd (SEQUENT):製薬・医療:M&Aディール及び事業提携情報
    Summary SeQuent Scientific Ltd (SeQuent) is a pharmaceutical company that develops and manufactures animal health API, life science and industrial products. The company offers products such as aciclovir sodium, albendazole, artemether, artesunate, amyl meta cresol, citicoline sodium and dihydroartem …
  • Ingersoll-Rand plc:企業の戦略・SWOT・財務情報
    Ingersoll-Rand plc - Strategy, SWOT and Corporate Finance Report Summary Ingersoll-Rand plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • SUPERVALU INC.:戦略・SWOT・企業財務分析
    SUPERVALU INC. - Strategy, SWOT and Corporate Finance Report Summary SUPERVALU INC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Hovnanian Enterprises Inc:戦略・SWOT・企業財務分析
    Hovnanian Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Hovnanian Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • University of Southern California-製薬・医療分野:企業M&A・提携分析
    Summary University of Southern California (USC) is a medical education and research institution that provides educational courses in the field of arts and sciences, accounting, architecture, art and design, arts and tech, business, cinematic arts, communication, journalism and dance. The institute a …
  • iX Biopharma Ltd (42C):企業の財務・戦略的SWOT分析
    Summary iX Biopharma Ltd (iX Biopharma) is a pharmaceutical company that provides that offers drug delivery and formulation. The company's pipeline product portfolio includes development of drugs for various indications such as opioid-sparing for acute, severe and chronic pain; male erectile dysfunc …
  • Toyota Motor Corp (7203):企業の財務・戦略的SWOT分析
    Toyota Motor Corp (7203) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Grand Haven Board of Light and Power:企業の戦略的SWOT分析
    Grand Haven Board of Light and Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Boditech Med Inc (206640):企業の製品パイプライン分析2018
    Summary Boditech Med Inc (Boditech) is a medical device company that manufactures and distributes in-vitro diagnostic analyzers and reagents. The company’s products include ichroma Reader, a portable fluorescence scanning instrument and AFIAS-6, a next-generation fluorescence processing and scanning …
  • Foundation Radiology Group PC:医療機器:M&Aディール及び事業提携情報
    Summary Foundation Radiology Group PC (FRG) is a provider of radiology solutions. The company offers radiological services in areas of pediatric, neurology, mammography, musculoskeletal, PET and CT, cardiac CT and interventional radiology. It offers imaging solutions for the radiologists and systems …
  • Micro Labs Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Micro Labs Ltd (Micro Labs) is a healthcare service organization which conducts research and development of bio equivalent generics. The organization’s business segments include formulations and active pharmaceutical ingredients. Its products include acetamide, allercet, amiodar, amlong, aml …
  • Public Financial Holdings Ltd (626):企業の財務・戦略的SWOT分析
    Public Financial Holdings Ltd (626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • American Armed Forces Mutual Aid Association:企業の戦略的SWOT分析
    American Armed Forces Mutual Aid Association - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Astellas Pharma Inc (4503):企業の財務・戦略的SWOT分析
    Astellas Pharma Inc (4503) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • GE Lighting LLC:企業の戦略的SWOT分析
    GE Lighting LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆